Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Monograph Reform Proposal Offers Two-Tier Approach

May 30 2017

• By Malcolm Spicer

FDA approved background, 3D rendering, blue street sign

Related Content

“No End In Sight” For Completing OTC Monographs – CDER Director Woodcock

Mar 26 2014

OTC Monograph User Fees Up To $34M Floated In Senate Discussion Draft

May 30 2017

OTC Monograph Application Reviews Get Deadlines, Not GRASE Flexibility

Nov 30 2016

Related Companies

Procter & Gamble

Additional Topics

United States Legislation FDA Dietary Supplements Regulation

More from Legislation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window